James Alexander Fagin MD
Diabetes, Lipid Metabolism, Thyroid
Head, Division of Subspecialty Medicine Memorial Sloan Kettering Cancer Center
Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Fagin
Dr. James Fagin is an endocrinologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of Buenos Aires and has been in practice 44 years. Dr. Fagin accepts several types of health insurance, listed below. He is one of 28 doctors at Memorial Sloan Kettering Cancer Center who specialize in Endocrinology. He also speaks multiple languages, including Spanish. He has more than 100 publications and over 500 citings.
Education & Training
Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985
University of Buenos AiresClass of 1973
Certifications & Licensure
CA State Medical License 1986 - Present
FL State Medical License 2021 - Present
NJ State Medical License 2021 - 2027
NY State Medical License 2006 - 2026
OH State Medical License 1995 - 2007
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2001
- Top Doctors: New York Metro Area Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 1995
Clinical Trials
- Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 Start of enrollment: 2009 Sep 01
- Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers Start of enrollment: 2020 Jun 26
Roles: Contact
Publications & Presentations
PubMed
- Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement.Sophie Leboulleux, Laura Boucai, Naifa Busaidy, Cosimo Durante, James A Fagin
The Lancet. Diabetes & Endocrinology. 2025-06-01 - 1 citationsRBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.Gnana P Krishnamoorthy, Anthony R Glover, Brian R Untch, Nickole Sigcha-Coello, Bin Xu
The Journal of Experimental Medicine. 2025-05-05 - 6 citationsHigh-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome.Daniel W Scholfield, Bin Xu, Helena Levyn, Alana Eagan, Ashok R Shaha
Thyroid. 2025-02-01
Journal Articles
- Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersSteven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism
- Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated with Decreased SurvivalJames Fagin, MD, The Journal of Clinical Endocrinology and Metabolism
- Methodology, Criteria and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor XenograftsJames A Fagin, Stephen D Rohl, Robert C Smallridge, Stefan K Grebe, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
Novel Agent Nixes Radioiodine Resistance in Thyroid CancerOctober 7th, 2020
Bench to Bedside: Translating Science from the Lab to the ClinicMay 2nd, 2019
87th Annual Meeting NewsOctober 20th, 2017- Join now to see all
Grant Support
- Targeting immune suppressive microenvironment in ATCSLOAN-KETTERING INST CAN RESEARCH2021–2026
- Targeting immune suppressive microenvironment in ATCSLOAN-KETTERING INST CAN RESEARCH2021–2026
- Improving efficacy of radioiodine treatment of thyroid cancerSLOAN-KETTERING INST CAN RESEARCH2021–2026
- Oncogenic Events In Thyroid NeoplasiaNational Cancer Institute2006–2012
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute2006–2012
- A Validated Resource Of Thyroid Cancer Cell Lines For Pathway DiscoveryNational Cancer Institute2009–2010
- Paracrine Igf/Gfbp Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2007
- Paracrine Igf/Gfbp Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
- Oncogenic Events In Thyroid NeoplasiaNational Cancer Institute1997–2006
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute1995–2004
- Biological And Physiological Sciences Review SectionCenter For Scientific Review2001–2002
- Paracrine IGF/IGFBP Interactions In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Center For Research Resources2000–2001
- N-Acetylcysteine As A Potential Treatment For Methamphetamine DependenceCenter For Scientific Review2000
- Insulin LIKE Growth Factor I In Arterial Wall InjuryNational Heart, Lung, And Blood Institute1995–1996
- Insulin LIKE Growth Factor I In Arterial Wall InjuryNational Heart, Lung, And Blood Institute1994
- Molecular Pathophysiology Of Thyroid Cell GrowthNational Cancer Institute1989–1993
- Tumor Suppressor Genes In Human Thyroid NeoplasmsNational Cancer Institute1990
- Human Growth Hormone-Secreting Hybrid CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1985–1986
Other Languages
- Spanish
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Kansas City Preferred-Care Blue PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
